Sign up for the premium plan and unlock all options
After purchasing the premium plan, you will unlock all information about drug prices and their availability.
Search
Listing 14761 - 14780 out of 495987 entries
| Country | ATC | Drug name | Drug form, strength, package | Price level | Price in € | Price in local currency | Therapeutic areas | Manufacturer / Importer |
|---|---|---|---|---|---|---|---|---|
| Australia | (XXXXX02) not known - dietetics | MSUD Explore5 containing 5 g of protein equivalent powder for oral liquid, 30 x 12.5 g sachets | Sachets containing oral powder 12.5 g, 30 (MSUD Explore5), 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
n/a | VitafloAustraliaPtyLimited |
| Australia | (XXXXX02) not known - dietetics | TYR Explore5 containing 5 g of protein equivalent powder for oral liquid, 30 x 12.5 g sachets | Sachets containing oral powder 12.5 g, 30 (TYR explore5), 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
n/a | VitafloAustraliaPtyLimited |
| Australia | (XXXXX02) not known - dietetics | Arginaid Extra Orange Burst oral liquid, 24 x 237 mL cartons | Oral liquid containing 4.5 g arginine in 237 mL, 24 (Arginaid Extra), 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
n/a | NestleAustraliaLtd |
| Australia | (G04BE08) tadalafil (adm: O) | Tadalis 20 mg tablet, 60 | Tablet 20 mg, 60 pcs | Wholesale price without vat |
$0-0 |
$0-0 |
n/a | CiplaAustraliaPtyLtd |
| Australia | (G04BE08) tadalafil (adm: O) | Tadalis 20 mg tablet, 60 | Tablet 20 mg, 60 pcs | Wholesale price without vat |
$0-0 |
$0-0 |
n/a | CiplaAustraliaPtyLtd |
| Australia | (J01CA04) amoxicillin | Cilamox 250 mg/5 mL powder for oral liquid, 100 mL | Powder for oral suspension 250 mg (as trihydrate) per 5 mL, 100 mL, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
n/a | AlphapharmPtyLtd |
| Australia | (J01CA04) amoxicillin | Cilamox 250 mg/5 mL powder for oral liquid, 100 mL | Powder for oral suspension 250 mg (as trihydrate) per 5 mL, 100 mL, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
n/a | AlphapharmPtyLtd |
| Australia | (J01DC04) cefaclor (adm: O) | Aclor 125 mg/5 mL powder for oral liquid, 100 mL | Powder for oral suspension 125 mg (as monohydrate) per 5 mL, 100 mL, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
n/a | AlphapharmPtyLtd |
| Australia | (J01DC04) cefaclor (adm: O) | Aclor 125 mg/5 mL powder for oral liquid, 100 mL | Powder for oral suspension 125 mg (as monohydrate) per 5 mL, 100 mL, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
n/a | AlphapharmPtyLtd |
| Australia | (J01DC04) cefaclor (adm: O) | Aclor 250 mg/5 mL powder for oral liquid, 75 mL | Powder for oral suspension 250 mg (as monohydrate) per 5 mL, 75 mL, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
n/a | AlphapharmPtyLtd |
| Australia | (J01DC04) cefaclor (adm: O) | Aclor 250 mg/5 mL powder for oral liquid, 75 mL | Powder for oral suspension 250 mg (as monohydrate) per 5 mL, 75 mL, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
n/a | AlphapharmPtyLtd |
| Australia | (L01FF05) atezolizumab | Tecentriq SC 1.875 g/15 mL injection, 15 mL vial | Solution for subcutaneous injection 1875 mg in 15 mL, 1 pcs | Ex-factory price without vat |
$0-0 |
$0-0 |
Carcinoma, Transitional Cell; Carcinoma, Non-Small-Cell Lung; Urologic Neoplasms; Breast Neoplasms; Small Cell Lung Carcinoma | RocheProductsPtyLtd |
| Australia | (L01FF05) atezolizumab | Tecentriq SC 1.875 g/15 mL injection, 15 mL vial | Solution for subcutaneous injection 1875 mg in 15 mL, 1 pcs | Ex-factory price without vat |
$0-0 |
$0-0 |
Carcinoma, Transitional Cell; Carcinoma, Non-Small-Cell Lung; Urologic Neoplasms; Breast Neoplasms; Small Cell Lung Carcinoma | RocheProductsPtyLtd |
| Australia | (L01FF05) atezolizumab | Tecentriq SC 1.875 g/15 mL injection, 15 mL vial | Solution for subcutaneous injection 1875 mg in 15 mL, 1 pcs | Ex-factory price without vat |
$0-0 |
$0-0 |
Carcinoma, Transitional Cell; Carcinoma, Non-Small-Cell Lung; Urologic Neoplasms; Breast Neoplasms; Small Cell Lung Carcinoma | RocheProductsPtyLtd |
| Australia | (L01FF05) atezolizumab | Tecentriq SC 1.875 g/15 mL injection, 15 mL vial | Solution for subcutaneous injection 1875 mg in 15 mL, 1 pcs | Ex-factory price without vat |
$0-0 |
$0-0 |
Carcinoma, Transitional Cell; Carcinoma, Non-Small-Cell Lung; Urologic Neoplasms; Breast Neoplasms; Small Cell Lung Carcinoma | RocheProductsPtyLtd |
| Australia | (L01FF05) atezolizumab | Tecentriq SC 1.875 g/15 mL injection, 15 mL vial | Solution for subcutaneous injection 1875 mg in 15 mL, 1 pcs | Ex-factory price without vat |
$0-0 |
$0-0 |
Carcinoma, Transitional Cell; Carcinoma, Non-Small-Cell Lung; Urologic Neoplasms; Breast Neoplasms; Small Cell Lung Carcinoma | RocheProductsPtyLtd |
| Australia | (L01FF05) atezolizumab | Tecentriq SC 1.875 g/15 mL injection, 15 mL vial | Solution for subcutaneous injection 1875 mg in 15 mL, 1 pcs | Ex-factory price without vat |
$0-0 |
$0-0 |
Carcinoma, Transitional Cell; Carcinoma, Non-Small-Cell Lung; Urologic Neoplasms; Breast Neoplasms; Small Cell Lung Carcinoma | RocheProductsPtyLtd |
| Australia | (L01FF05) atezolizumab | Tecentriq SC 1.875 g/15 mL injection, 15 mL vial | Solution for subcutaneous injection 1875 mg in 15 mL, 1 pcs | Ex-factory price without vat |
$0-0 |
$0-0 |
Carcinoma, Transitional Cell; Carcinoma, Non-Small-Cell Lung; Urologic Neoplasms; Breast Neoplasms; Small Cell Lung Carcinoma | RocheProductsPtyLtd |
| Australia | (L01FF05) atezolizumab | Tecentriq SC 1.875 g/15 mL injection, 15 mL vial | Solution for subcutaneous injection 1875 mg in 15 mL, 1 pcs | Ex-factory price without vat |
$0-0 |
$0-0 |
Carcinoma, Transitional Cell; Carcinoma, Non-Small-Cell Lung; Urologic Neoplasms; Breast Neoplasms; Small Cell Lung Carcinoma | RocheProductsPtyLtd |
| Australia | (L04AB04) adalimumab (adm: P) | Abrilada 40 mg/0.8 mL injection, 2 x 0.8 mL pen devices | Injection 40 mg in 0.8 mL pre-filled pen, 2 pcs | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | PfizerAustraliaPtyLtd |
Pages
